We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$991M
AUM Growth
+$260M
Cap. Flow
+$254M
Cap. Flow %
25.68%
Top 10 Hldgs %
35.1%
Holding
398
New
299
Increased
7
Reduced
3
Closed
88
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPVA.U
201
DELISTED
InterPrivate II Acquisition Corp. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVA.U
$989K 0.1%
+100,000
New +$997K
ATSPU
202
DELISTED
Archimedes Tech SPAC Partners Co. Unit
ATSPU
$989K 0.1%
+100,000
New +$989K
OPA.U
203
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
$989K 0.1%
+100,000
New +$988K
KSICU
204
DELISTED
Kadem Sustainable Impact Corporation Unit
KSICU
$988K 0.1%
+100,000
New +$989K
TWNT.U
205
DELISTED
Tailwind Two Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of
TWNT.U
$988K 0.1%
+100,000
New +$1,000K
BGSX.U
206
DELISTED
Build Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
BGSX.U
$987K 0.1%
+100,000
New +$990K
AFAQU
207
DELISTED
AF Acquisition Corp Units
AFAQU
$987K 0.1%
+100,000
New +$982K
VPCC.U
208
DELISTED
VPC Impact Acquisition Holdings III, Inc. Units, each consisting of one share of Class A common stoc
VPCC.U
$987K 0.1%
+100,000
New +$997K
VPCBU
209
DELISTED
VPC Impact Acquisition Holdings II Unit
VPCBU
$986K 0.1%
+100,000
New +$999K
GNAC
210
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
$986K 0.1%
+100,000
New +$989K
IPVF.U
211
DELISTED
InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVF.U
$986K 0.1%
+100,000
New +$997K
CLAA.U
212
DELISTED
Colonnade Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
CLAA.U
$985K 0.1%
+100,000
New +$996K
CAS
213
DELISTED
Cascade Acquisition Corp.
CAS
$985K 0.1%
+100,000
New +$1.01M
PTK
214
DELISTED
PTK Acquisition Corp.
PTK
$985K 0.1%
+100,000
New +$1.02M
FCAX
215
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$981K 0.1%
+100,000
New +$986K
TACA
216
DELISTED
Trepont Acquisition Corp I
TACA
$981K 0.1%
+100,000
New +$1.01M
PDYN icon
217
Palladyne AI
PDYN
$228M
$980K 0.1%
+16,667
New +$975K
DLCA
218
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$980K 0.1%
+100,000
New +$978K
CFIV
219
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$979K 0.1%
+100,000
New +$1M
EPHY
220
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$979K 0.1%
+100,000
New +$983K
PPGH
221
DELISTED
Poema Global Holdings Corp. Class A Ordinary Share
PPGH
$978K 0.1%
+100,000
New +$978K
EFTR
222
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$975K 0.1%
+4,000
New +$982K
HLAH
223
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$975K 0.1%
+99,999
New +$977K
PMGM
224
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$974K 0.1%
+100,000
New +$981K
LDTC
225
DELISTED
LeddarTech
LDTC
$973K 0.1%
+200,000
New +$985K

Similar funds

Mangrove Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Mangrove Partners held 398 positions worth $991M, up 36% from $731M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mangrove Partners deployed $254M of net new capital in Q1 2021, opening 299 new positions and adding to 7 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 7.8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Navios Maritime Containers L.P. Common Units, an estimated $12.7M trimmed.

  • Mangrove Partners's largest Q1 2021 buy was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.
  • Mangrove Partners added most to Pershing Square Tontine Holdings, Ltd. in Q1 2021, an estimated $27.1M increase.
  • Mangrove Partners's biggest Q1 2021 reduction was Navios Maritime Containers L.P. Common Units, cutting an estimated $12.7M.
  • Mangrove Partners fully exited TG Therapeutics in Q1 2021, selling an estimated $17.7M.
  • Mangrove Partners's ten largest holdings make up 35% of its $991M portfolio in Q1 2021.
  • Mangrove Partners opened 299 new positions and closed 88 in Q1 2021.
  • Mangrove Partners's portfolio value rose 36% quarter-over-quarter to $991M.

Based on Mangrove Partners's 13F filing for Q1 2021, filed 17 May 2021.